Study details
Enrolling now
Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children
University of California, Davis
NCT IDNCT04724252ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2/3
Target enrollment
60
Study length
about 5.4 years
Ages
≤17
Locations
1 site in CA
What this study is about
Researchers are testing if giving gabapentin to children after surgery reduces the need for opioid pain medication. The trial will last 1956 days and involve approximately 60 children.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take Gabapentin
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
gabapentin (Modulates calcium channels; used for neuropathic pain and seizures)
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Amount of pain medication needed.